Resistance to an anti-malaria drug, artemisinin, is suspected along the Thailand-Myanmar border and in southern Vietnam, but scientists are hoping that it can be contained. Artemisinin resistance emerged on the Thailand-Cambodia border around eight years ago.
Resistance – the ability of the malaria parasite to survive drugs intended to kill it quickly – to chloroquine, an antimalarial previously widely used, forced treatment to change in the early 1970s and also originated in what is known as the Greater Mekong sub-region, which includes Cambodia, the southern provinces of China, Lao, Myanmar, Thailand and Viet Nam.
Chloroquine resistance spread to India and then to sub-Saharan Africa, which has the world’s highest burden of the disease.
Decades later, faced with another bout of resistance, officials are cautiously optimistic about preventing the spread of resistance to artemisinin.
“So far, we haven’t found any artemisinin resistance outside the Mekong region… I think we have good chances to keep it in the Mekong region,” Pascal Ringwald, coordinator of the global malaria programme for the World Health Organization (WHO), told a meeting of experts on antimalarial drug resistance in Bangkok.
He noted that the suspected cases of drug resistance along the two Thai borders appeared to be “totally independent, and it raises a concern that it could emerge anywhere.”
Roots of resistance
Resistance to artemisinin is not necessarily fatal for patients because partner drugs can boost its efficacy when it falters, but treatment may take longer and be more expensive.
Studies published earlier in April, covering more than 3,200 patients along the northwestern border of Thailand near Myanmar from 2001 to 2010, indicated a steady increase in drug resistance from 0.6 percent of surveyed patients to 20 percent after a decade.
Scientists are still searching for the exact causes of the resistance, but link it to the widespread use of monotherapies, in which only artemisinin is prescribed.
Despite an international resolution addressing the danger of monotherapies, 25 countries and 28 pharmaceutical companies continue to market them.
Monotherapies are easier and less expensive to manufacture and market than combination therapies, which pair artemisinin with other drugs (artemisinin combination therapies, or ACTs) but they speed the development of resistance to artemisinin in malaria parasites. According to WHO, the parasite is highly unlikely to become drug resistant to ACTs.
Other possible factors in resistance are parasite biology, human behaviour (like not taking the correct dosage or type of antimalaria drugs) and counterfeit drugs.
The Role of Telemedicine Today: During and Beyond the COVID-19
Lockdowns, quarantine periods, and hospitals fast filling to the brink needed the medical community to come up with solutions fast. Telemedicine was uniquely placed to help solve many of these problems.
Southeast Asia Covid-19 Latest News
The Delta variant has ripped through Southeast Asia in recent weeks, undoing many countries’ progress against the Covid-19 pandemic. Indonesia has been hit especially hard.
Can border reopening revive tourism in South-East Asia?
In Thailand, where pre-pandemic tourism accounted for 11-12% of GDP, the country lost an estimated $50bn last year as Covid-19...
Thailand dropped from UK’s tough covid-19 travel ‘red list’
Earlier, Thailand was listed among countries with high infection levels that were put on a ‘red list’, requiring arrivals to...
The ASEAN-Russia Trade and Investment Cooperation Work Program
ASEAN and Russia recently agreed to enhance and widen economic cooperation at the 10th ASEAN Economic Ministers (AEM)-Russia Consultations held...
Flexible Workspace Startup Worklounge Debuts with 20+ Luxury Member Lounges in Thailand
Worklounge launches a premium membership granting remote professionals and executives access to exclusive hotel lounges across Thailand. Their platform is...
5 insights to guide ASEAN’s digital generation in a post-pandemic world
We surveyed 86,000 people from six ASEAN countries about their views for a post-pandemic world. The ASEAN Digital Generation Report...